TY - JOUR
T1 - Timing of Physical Activity, Apolipoprotein E ε4 Genotype, and Risk of Incident Mild Cognitive Impairment
AU - Krell-Roesch, Janina
AU - Pink, Anna
AU - Roberts, Rosebud O.
AU - Stokin, Gorazd B.
AU - Mielke, Michelle M.
AU - Spangehl, Kathleen A.
AU - Bartley, Mairead M.
AU - Knopman, David S.
AU - Christianson, Teresa J.H.
AU - Petersen, Ronald C.
AU - Geda, Yonas E.
N1 - Funding Information:
Conflict of Interest: David S. Knopman is Deputy Editor of Neurology and an investigator in clinical trials sponsored by Baxter and Elan Pharmaceuticals in the past 2 years; receives research support from NIH; is a consultant to Tau RX; and serves on a Data Safety Monitoring Board for Lundbeck Pharmaceuticals and the Dominantly Inherited Alzheimer's Disease Treatment Unit. He has served on a Data Safety Monitoring Board for Lilly Pharmaceuticals. Ronald C. Petersen is a consultant to Roche, Inc., Merck, and Genentech and serves as chair of data monitoring committees of Pfizer, Inc. and Jannsen Alzheimer Immunotherapy. Support for this research was provided by National Institutes of Health (NIH) grants: National Institute of Mental Health (K01 MH068351), National Institute on Aging (U01 AG006786 and K01 AG028573) and NIH Grant (R01 AG034676 - Multimorbidity and Aging: Rochester Epidemiology Project). This project was also supported by the Robert Wood Johnson Foundation, the Robert H. and Clarice Smith and Abigail Van Buren Alzheimer's Disease Research Program, the European Regional Development Fund: FNUSA-ICRC (No. CZ.1.05/1.1.00/02.0123), and the Arizona Alzheimer's Consortium. Author Contributions: Dr. Geda had full access to all data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Krell-Roesch, Roberts, Petersen, Geda: study concept and design. Krell-Roesch, Pink, Roberts, stokin, Mielke, Christianson, Geda: acquisition, analysis, or interpretation of data. Krell-Roesch, Geda: drafting of the manuscript. Pink, Roberts, Stokin, Mielke, Spangehl, Bartley, Knopman, Petersen: critical revision of the manuscript for important intellectual content. Christianson: statistical analysis. Stokin, Petersen, Geda: obtained funding. Roberts, Stokin, Petersen, Geda: administrative, technical, or material support. Sponsor's Role: The funding sources had no role in the design or conduct of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.
Publisher Copyright:
© 2016, Copyright the Authors Journal compilation © 2016, The American Geriatrics Society
PY - 2016/12/1
Y1 - 2016/12/1
N2 - Objectives: To investigate the timing (mid- vs late life) of physical activity, apolipoprotein (APO)E ε4, and risk of incident mild cognitive impairment (MCI). Design: Prospective cohort study. Setting: Mayo Clinic Study of Aging (Olmsted County, MN). Participants: Cognitively normal elderly adults (N = 1,830, median age 78, 50.2% female). Measurements: Light, moderate, and vigorous physical activities in mid- and late life were assessed using a validated questionnaire. An expert consensus panel measured MCI based on published criteria. Cox proportional hazards models were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) with age as a time scale after adjusting for sex, education, medical comorbidity, and depression. Results: Light (HR = 0.58, 95% CI = 0.43–0.79) and vigorous (HR = 0.78, 95% CI = 0.63–0.97) physical activity in midlife were associated with lower risk of incident MCI. The association between moderate activity and incident MCI was not significant (HR = 0.85, 95% CI = 0.67–1.09). In late life, light (HR = 0.75, 95% CI = 0.58–0.97) and moderate (HR = 0.81, 95% CI = 0.66–0.99) but not vigorous physical activity were associated with lower risk of incident MCI. A synergistic interaction was also observed between mid- and late-life activity in reducing risk of incident MCI. Furthermore, APOE ε4 carriers who did not exercise had a higher risk of incident MCI than noncarriers who reported physical activity. Conclusion: Physical activity reduced the risk of incident MCI. Exercising in mid- and late life had an additive synergistic interaction in reducing the risk of MCI.
AB - Objectives: To investigate the timing (mid- vs late life) of physical activity, apolipoprotein (APO)E ε4, and risk of incident mild cognitive impairment (MCI). Design: Prospective cohort study. Setting: Mayo Clinic Study of Aging (Olmsted County, MN). Participants: Cognitively normal elderly adults (N = 1,830, median age 78, 50.2% female). Measurements: Light, moderate, and vigorous physical activities in mid- and late life were assessed using a validated questionnaire. An expert consensus panel measured MCI based on published criteria. Cox proportional hazards models were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) with age as a time scale after adjusting for sex, education, medical comorbidity, and depression. Results: Light (HR = 0.58, 95% CI = 0.43–0.79) and vigorous (HR = 0.78, 95% CI = 0.63–0.97) physical activity in midlife were associated with lower risk of incident MCI. The association between moderate activity and incident MCI was not significant (HR = 0.85, 95% CI = 0.67–1.09). In late life, light (HR = 0.75, 95% CI = 0.58–0.97) and moderate (HR = 0.81, 95% CI = 0.66–0.99) but not vigorous physical activity were associated with lower risk of incident MCI. A synergistic interaction was also observed between mid- and late-life activity in reducing risk of incident MCI. Furthermore, APOE ε4 carriers who did not exercise had a higher risk of incident MCI than noncarriers who reported physical activity. Conclusion: Physical activity reduced the risk of incident MCI. Exercising in mid- and late life had an additive synergistic interaction in reducing the risk of MCI.
KW - APOE e4
KW - mild cognitive impairment
KW - physical activity
UR - http://www.scopus.com/inward/record.url?scp=84996743351&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84996743351&partnerID=8YFLogxK
U2 - 10.1111/jgs.14402
DO - 10.1111/jgs.14402
M3 - Article
C2 - 27801933
AN - SCOPUS:84996743351
SN - 0002-8614
VL - 64
SP - 2479
EP - 2486
JO - Journal of the American Geriatrics Society
JF - Journal of the American Geriatrics Society
IS - 12
ER -